CheckMyRecalls

10,013 recalls · updated 20 Nov 2026

Acella Pharmaceuticals, LLC recalls NAPROXEN ORAL SUSPENSION

Read the official FDA notice

Published
13 May 2026
Units affected
6,336 bottles
Agency
FDA
Country
United States

The hazard

Chemical contamination; presence of lead and lithium above specification

Classification: Class II — this product may cause temporary or medically reversible health problems; the chance of serious harm is remote.

What to do

Do not stop a prescribed medicine without talking to your doctor or pharmacist first. Ask them about a replacement, and return the recalled product to the pharmacy.

  • Check the lot number on the box or bottle.
  • Talk to your pharmacist or doctor before stopping any prescribed medicine.
  • Return the product to the pharmacy for safe disposal.
Read the official FDA notice

Product details

NAPROXEN ORAL SUSPENSION, USP, 125 mg/5mL, Rx only, 16fl oz (473 mL) bottles, Distributed by: Acella Pharmaceuticals, LLC, Alpharetta, GA 30005, Made in Canada NDC 42192-619-16

Brand / company
Acella Pharmaceuticals, LLC
Codes / lots
Lot: 23F02, Expires: 05/2026; 25A37, Expires: 01/2028.
Distribution
Nationwide
Recall status
Ongoing

Source: U.S. Food and Drug Administration, published 13 May 2026. CheckMyRecalls reproduces the official notice in summary; always confirm the details with the original notice.